2211 — Universal Health International Holding Cashflow Statement
0.000.00%
- HK$70.49m
- HK$40.47m
- CNY1.09bn
- 10
- 100
- 28
- 42
Annual cashflow statement for Universal Health International Holding, fiscal year end - June 30th, CNY millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -493 | -676 | -188 | -106 | 0.58 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -7.97 | 233 | 18.3 | 26.6 | -27.1 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 49.5 | 227 | 101 | 45.1 | -89.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -408 | -108 | -42.4 | -18.2 | -102 |
Capital Expenditures | -95.7 | -1.9 | -0.101 | -0.061 | -0.017 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.417 | 21.6 | 11.2 | -7.96 | 54.9 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -96.1 | 19.7 | 11.1 | -8.02 | 54.9 |
Financing Cash Flow Items | 0 | — | — | — | 30.6 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 7.08 | -10.2 | 56 | 11.3 | 40.2 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -497 | -98.2 | 24.7 | -14.8 | -6.63 |